Effects of Misonidazole and Cyclophosphamide on Tumor Cells
Author Information
Author(s): C. Grau, S.M. Bentzen, J. Overgaard
Primary Institution: The Danish Cancer Society, Department of Experimental Clinical Oncology
Hypothesis
The study investigates the chemosensitizing effect of misonidazole on cyclophosphamide in a C3H mammary carcinoma.
Conclusion
Misonidazole enhances the cytotoxic effect of cyclophosphamide on aerobic tumor cells, but not on hypoxic cells.
Supporting Evidence
- CTX was found to be considerably more toxic towards hypoxic than aerobic cells.
- MISO was almost exclusively toxic to hypoxic cells.
- The combination of MISO and CTX resulted in a significant decrease in the surviving fraction of aerobic cells.
Takeaway
This study shows that a drug called misonidazole can help another drug, cyclophosphamide, work better against certain cancer cells, but it doesn't help with all types of cancer cells.
Methodology
The study used a local tumor control assay to measure the effects of misonidazole and cyclophosphamide on tumor cells in mice.
Limitations
The exact mechanisms of chemosensitization and the role of hypoxia require further research.
Participant Demographics
10-12-week-old male C3D2F1 mice
Statistical Information
P-Value
p<0.01 for MISO, p<0.001 for CTX
Confidence Interval
95% confidence intervals provided for various measurements
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website